Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for ...

Fact checked by Nick Blackmer Experts have warned of the “triple threat”—influenza, COVID-19, and respiratory syncytial virus ...

Early results from 63 of the infants enrolled in the trial found the vaccine to be safe, tolerated and able to cut the chance ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.DyCR3BqR.js ...

A Triad infectious disease expert says COVID-19, flu and RSV are among the top respiratory illnesses to watch out for as ...

Postmortem RSV detection rate is reported as a percentage of RSV-positive cases among all-cause or respiratory deaths. To try to systematize the substantial variability in age group categories applied ...

Exploring other people's motivations with empathy, respect and curiosity, instead of judgment, is at the core of effective ...

New York City data highlight the benefits of early administration of nirsevimab to safeguard infants from respiratory ...

Finding a cure for colds and the flu is tricky to say the least, but new science may help you prevent them or at least ...

CIDRAP: Recombinant Pertussis Vaccine May Protect Teens For At Least 5 Years Researchers report that immunity against pertussis (whooping cough) was sustained 5 years after receipt of a ...

In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...